Clinical Trial Update: Higher Dose Preoperative taMOxifen in Premenopausal bREast Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 trial update evaluating a higher dose of preoperative taMOxifen in premenopausal women with hormone receptor-positive breast cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Hormone Receptor-positive Breast Cancer
• Premenopausal Breast Cancer

Drugs mentioned

• Tamoxifen (tamoxifen)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Premenopausal Breast Cancer, Hormone Receptor-positive Breast Cancer | Phase 2 | Status: ACTIVE_NOT_RECRUITING